Is Indaptus Therapeutics, Inc. (INDP) a Buy, Sell, or Hold?
NASDAQ : INDP
Indaptus Therapeutics, Inc. — Insider Trades
$2.54 USD
$0.08 (3.25%)
- Volume
- 8.5K
- Average Volume
- 1.01M
- Market Capitalization
- $4.45M
- P/E Ratio
- -0.40
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.91
- Year Low
- $0.92
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.34
Insider Activity Summary (Last 12 Months)
Insiders Buying
19
Insiders Selling
5
Amount of Insider Selling
$913.49K
INDP Insider Buying/Selling by Quarter
INDP Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Lu Qinglai | director: | 2026-04-08 | 0 | 2026-04-20 | |
| Yao Yun | 10 percent owner | 2026-03-23 | 0 | 2026-04-02 | |
| SINO LION VENTURES Ltd | 10 percent owner | 2026-03-23 | 0 | 2026-04-02 | |
| Dai Junyi | officer: Chief Executive Officer | 2026-03-23 | 0 | 2026-04-02 | |
| Lazar David E. | director | 2026-03-23 | S-Sale | 0 | 2026-03-24 |
| Lazar David E. | director | 2026-03-23 | S-Sale | 0 | 2026-03-24 |
| Jabbour Jerome D | director | 2026-02-26 | A-Award | 2.06 | 2026-02-27 |
| Jabbour Jerome D | director: | 2026-02-26 | 0 | 2026-02-27 | |
| McMurdo Matthew Charles | director | 2026-02-26 | 0 | 2026-02-26 | |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | 2026-02-11 | A-Award | 1.75 | 2026-02-13 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | 2026-02-11 | A-Award | 1.75 | 2026-02-13 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | 2026-02-11 | A-Award | 1.75 | 2026-02-13 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | 2026-02-11 | D-Return | 8.3 | 2026-02-13 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | 2026-02-11 | D-Return | 47.6 | 2026-02-13 |
| Meckler Jeffrey A | director, officer: Co-Chief Executive Officer | 2026-02-11 | D-Return | 29.4 | 2026-02-13 |
| Ben-Tzvi Avraham | director | 2026-01-20 | A-Award | 0 | 2026-01-22 |
| Ben-Tzvi Avraham | director | 2025-12-23 | A-Award | 1.95 | 2026-01-22 |
| NATAN DAVID | director | 2026-01-07 | A-Award | 2.69 | 2026-01-22 |
| NATAN DAVID | director | 2026-01-08 | 0 | 2026-01-12 | |
| Sassi Nir | officer: Chief Financial Officer | 2025-12-22 | A-Award | 2.03 | 2025-12-29 |
| Meckler Jeffrey A | director, 10 percent owner, officer: Co-Chief Executive Officer | 2025-12-22 | A-Award | 2.03 | 2025-12-29 |
| Newman Michael James | director, officer: CSO and Director | 2025-12-22 | A-Award | 2.03 | 2025-12-29 |
| Linscott Walt Addison | officer: Chief Operating Officer | 2025-12-22 | A-Award | 2.03 | 2025-12-29 |
| Lazar David E. | officer: Co-Chief Executive Officer | 2025-12-22 | 0 | 2025-12-23 | |
| Lazar David E. | officer: Co-Chief Executive Officer | 2025-12-22 | 0 | 2025-12-23 | |
| Lazar David E. | officer: Co-Chief Executive Officer | 2025-12-22 | 0 | 2025-12-23 | |
| Ben-Tzvi Avraham | director | 2025-12-22 | 0 | 2025-12-23 | |
| Meckler Jeffrey A | director, officer: Chief Executive Officer | 2025-07-27 | A-Award | 8.3024 | 2025-07-29 |
| Meckler Jeffrey A | director, officer: Chief Executive Officer | 2025-07-27 | A-Award | 8.3024 | 2025-07-29 |
| Karah Hila | director | 2025-06-10 | A-Award | 0.33 | 2025-06-11 |
| Martell Robert | director | 2025-06-10 | A-Award | 0.33 | 2025-06-11 |
| Hayes William B | director | 2025-06-10 | A-Award | 0.33 | 2025-06-11 |
| MADDALUNA ANTHONY J | director | 2025-06-10 | A-Award | 0.33 | 2025-06-11 |
| Pomerantz Roger | director | 2025-06-10 | A-Award | 0.33 | 2025-06-11 |
| Gilbert Mark John | director | 2025-06-10 | A-Award | 0.33 | 2025-06-11 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2024-11-25 | A-Award | 1.175 | 2024-11-26 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2024-11-25 | A-Award | 1.05 | 2024-11-26 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | 2024-10-09 | A-Award | 1.105 | 2024-10-10 |
| Sassi Nir | officer: Chief Financial Officer | 2024-10-09 | A-Award | 1.105 | 2024-10-10 |
| Waltzman Roger J. | officer: Chief Medical Officer | 2024-10-09 | A-Award | 1.105 | 2024-10-10 |
| Linscott Walt Addison | officer: Chief Operating Officer | 2024-10-09 | A-Award | 1.105 | 2024-10-10 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2024-10-09 | A-Award | 1.105 | 2024-10-10 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2024-08-08 | A-Award | 1.825 | 2024-08-08 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2024-08-08 | A-Award | 1.7 | 2024-08-08 |
| Karah Hila | director | 2024-06-06 | A-Award | 2.63 | 2024-06-07 |
| Gilbert Mark John | director | 2024-06-06 | A-Award | 2.63 | 2024-06-07 |
| Pomerantz Roger | director | 2024-06-06 | A-Award | 2.63 | 2024-06-07 |
| MADDALUNA ANTHONY J | director | 2024-06-06 | A-Award | 2.63 | 2024-06-07 |
| Martell Robert | director | 2024-06-06 | A-Award | 2.63 | 2024-06-07 |
| Hayes William B | director | 2024-06-06 | A-Award | 2.63 | 2024-06-07 |
| Linscott Walt Addison | officer: Chief Operating Officer | 2024-01-22 | A-Award | 1.74 | 2024-01-23 |
| Waltzman Roger J. | officer: Chief Medical Officer | 2024-01-22 | A-Award | 1.74 | 2024-01-23 |
| Sassi Nir | officer: Chief Financial Officer | 2024-01-22 | A-Award | 1.74 | 2024-01-23 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2024-01-22 | A-Award | 1.74 | 2024-01-23 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | 2024-01-22 | A-Award | 1.74 | 2024-01-23 |
| Anderson Glen R. | 10 percent owner | 2023-08-14 | P-Purchase | 2.34 | 2023-08-16 |
| Anderson Glen R. | 10 percent owner | 2023-08-11 | P-Purchase | 2.12 | 2023-08-16 |
| Anderson Glen R. | 10 percent owner | 2023-08-10 | P-Purchase | 1.94 | 2023-08-16 |
| Waltzman Roger J. | officer: Chief Medical Officer | 2023-08-07 | A-Award | 1.85 | 2023-08-07 |
| Waltzman Roger J. | officer | 2023-08-07 | 0 | 2023-08-07 | |
| Karah Hila | director | 2023-05-25 | A-Award | 1.82 | 2023-05-30 |
| Hayes William B | director | 2023-05-25 | A-Award | 1.82 | 2023-05-30 |
| Gilbert Mark John | director | 2023-05-25 | A-Award | 1.82 | 2023-05-30 |
| Pomerantz Roger | director | 2023-05-25 | A-Award | 1.82 | 2023-05-30 |
| MADDALUNA ANTHONY J | director | 2023-05-25 | A-Award | 1.82 | 2023-05-30 |
| Martell Robert | director | 2023-02-13 | A-Award | 1.71 | 2023-02-14 |
| Martell Robert | director: | 2023-02-13 | 0 | 2023-02-14 | |
| Meckler Jeffrey A | officer: CEO and Director | 2023-01-18 | A-Award | 0 | 2023-01-20 |
| Linscott Walt Addison | officer: Chief Business Officer | 2023-01-18 | A-Award | 0 | 2023-01-20 |
| Sassi Nir | officer: Chief Financial Officer | 2023-01-18 | A-Award | 0 | 2023-01-20 |
| Newman Michael James | officer: CSO and Director | 2023-01-18 | A-Award | 0 | 2023-01-20 |
| Litchev Boyan Vesselinov | officer: Chief Medical Officer | 2022-12-01 | P-Purchase | 1.8709 | 2022-12-19 |
| Litchev Boyan Vesselinov | officer: Chief Medical Officer | 2022-11-22 | P-Purchase | 1.83 | 2022-12-19 |
| Litchev Boyan Vesselinov | officer: Chief Medical Officer | 2022-03-02 | P-Purchase | 4.0926 | 2022-12-19 |
| Litchev Boyan Vesselinov | officer: Chief Medical Officer | 2022-01-31 | P-Purchase | 4.65 | 2022-12-19 |
| Meckler Jeffrey A | officer: CEO and Director | 2022-11-21 | P-Purchase | 1.9 | 2022-11-22 |
| Meckler Jeffrey A | officer: CEO and Director | 2022-11-18 | P-Purchase | 1.7637 | 2022-11-22 |
| Karah Hila | director: | 2022-09-30 | A-Award | 0 | 2022-10-03 |
| Pomerantz Roger | director: | 2022-09-30 | A-Award | 0 | 2022-10-03 |
| Gilbert Mark John | director: | 2022-09-30 | A-Award | 0 | 2022-10-03 |
| O'CALLAGHAN BRIAN | director: | 2022-09-30 | A-Award | 0 | 2022-10-03 |
| MADDALUNA ANTHONY J | director: | 2022-09-30 | A-Award | 0 | 2022-10-03 |
| Hayes William B | director: | 2022-09-30 | A-Award | 0 | 2022-10-03 |
| Meckler Jeffrey A | officer: CEO and Director | 2022-09-08 | P-Purchase | 2.8 | 2022-09-12 |
| Linscott Walt Addison | officer: Chief Business Officer | 2022-09-07 | P-Purchase | 2.62 | 2022-09-09 |
| Meckler Jeffrey A | officer: CEO and Director | 2022-09-06 | P-Purchase | 2.57 | 2022-09-08 |
| Anderson Glen R. | 10 percent owner | 2022-06-27 | 0 | 2022-07-07 | |
| Anderson Glen R. | 10 percent owner | 2022-06-27 | 0 | 2022-07-07 | |
| Meckler Jeffrey A | officer: CEO and Director | 2022-06-06 | P-Purchase | 2.63 | 2022-06-07 |
| Sassi Nir | officer: Chief Financial Officer | 2022-02-25 | A-Award | 4.18 | 2022-02-28 |
| Litchev Boyan Vesselinov | officer: Chief Medical Officer | 2022-02-01 | A-Award | 4.97 | 2022-02-02 |
| Litchev Boyan Vesselinov | officer | 2022-01-31 | 0 | 2022-02-02 | |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | 2022-01-31 | S-Sale | 5.0001 | 2022-02-02 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | 2022-02-01 | S-Sale | 5.003 | 2022-02-02 |
| Newman Michael James | director, 10 percent owner, officer: CSO and Director | 2022-01-26 | A-Award | 4.9 | 2022-01-28 |
| Meckler Jeffrey A | director, officer: CEO and Director | 2022-01-26 | A-Award | 4.9 | 2022-01-28 |
| Linscott Walt Addison | officer: Chief Business Officer | 2022-01-26 | A-Award | 4.9 | 2022-01-28 |
| Gilbert Mark John | director | 2021-12-01 | A-Award | 5.35 | 2021-12-08 |
| Gilbert Mark John | director: | 2021-11-29 | 0 | 2021-12-08 | |
| Meckler Jeffrey A | director, officer: CEO and Director | 2021-11-18 | P-Purchase | 5.82 | 2021-11-19 |